Merit Medical Systems Long Term Debt 2010-2023 | MMSI
Merit Medical Systems long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Merit Medical Systems Annual Long Term Debt
(Millions of US $) |
| 2023 |
$823 |
| 2022 |
$187 |
| 2021 |
$234 |
| 2020 |
$344 |
| 2019 |
$432 |
| 2018 |
$373 |
| 2017 |
$259 |
| 2016 |
$314 |
| 2015 |
$198 |
| 2014 |
$214 |
| 2013 |
$239 |
| 2012 |
$228 |
| 2011 |
$31 |
| 2010 |
$82 |
| 2009 |
$ |
Merit Medical Systems Quarterly Long Term Debt
(Millions of US $) |
| 2023-12-31 |
$823 |
| 2023-09-30 |
$282 |
| 2023-06-30 |
$335 |
| 2023-03-31 |
$186 |
| 2022-12-31 |
$187 |
| 2022-09-30 |
$205 |
| 2022-06-30 |
$236 |
| 2022-03-31 |
$243 |
| 2021-12-31 |
$234 |
| 2021-09-30 |
$271 |
| 2021-06-30 |
$285 |
| 2021-03-31 |
$313 |
| 2020-12-31 |
$344 |
| 2020-09-30 |
$350 |
| 2020-06-30 |
$403 |
| 2020-03-31 |
$438 |
| 2019-12-31 |
$432 |
| 2019-09-30 |
$432 |
| 2019-06-30 |
$385 |
| 2019-03-31 |
$362 |
| 2018-12-31 |
$373 |
| 2018-09-30 |
$187 |
| 2018-06-30 |
$392 |
| 2018-03-31 |
$366 |
| 2017-12-31 |
$259 |
| 2017-09-30 |
$261 |
| 2017-06-30 |
$225 |
| 2017-03-31 |
$220 |
| 2016-12-31 |
$314 |
| 2016-09-30 |
$318 |
| 2016-06-30 |
$222 |
| 2016-03-31 |
$218 |
| 2015-12-31 |
$198 |
| 2015-09-30 |
$200 |
| 2015-06-30 |
$200 |
| 2015-03-31 |
$203 |
| 2014-12-31 |
$214 |
| 2014-09-30 |
$230 |
| 2014-06-30 |
$238 |
| 2014-03-31 |
$244 |
| 2013-12-31 |
$239 |
| 2013-09-30 |
$241 |
| 2013-06-30 |
$247 |
| 2013-03-31 |
$244 |
| 2012-12-31 |
$228 |
| 2012-09-30 |
$65 |
| 2012-06-30 |
$57 |
| 2012-03-31 |
$53 |
| 2011-12-31 |
$31 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$55 |
| 2011-03-31 |
$83 |
| 2010-12-31 |
$82 |
| 2010-09-30 |
$88 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.299B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
